Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Int J Mol Sci · 2024 · PMC11012872 · PMID 38612799

Europe PMC DOI

hedged sentence

0.3200

closest p · 6.4× alpha

0.3200

boldest claim

The sentences

a nonsignificant trendp = 0.32not close (p > 0.1)

Moreover, a poor ECOG performance status showed a nonsignificant trend for predicting shorter PFS (ECOG PS 0 versus ECOG PS ≥ 1, 4 months versus 7 months, HR = 0.585 (0.358–0.956, p = 0.32).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.